Search results
Dr. Reddy’s Laboratories Limited (NYSE:RDY) Q4 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 hour agoDr. Reddy’s Laboratories Limited (NYSE:RDY) Q4 2024 Earnings Call Transcript May 7, 2024 Dr. Reddy’s...
Viatris (VTRS) to Report Q1 Earnings: Is a Beat in Store?
Zacks via Yahoo Finance· 2 days agoOther Stocks to Consider Here are some other drug and biotech stocks that you may want to consider,...
Sandoz reports first quarter 2024 sales - Sandoz Group (OTC:SDZNY)
Benzinga· 2 days agoAd hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Strong first quarter performance, with net sales [1] of USD 2.5 billion, up 6% in constant currencies (up 5% in
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 17 hours ago(NASDAQ: GDRX), Autodesk, Inc. (NASDAQ: ADSK), Global Cord Blood Corporation (OTC: CORBF), and Lincoln National Corporation (NYSE: LNC). Stockholders have until the deadlines ...
C21 Investments Announces Preliminary Year-End Results - C21 Investments (OTC:CXXIF)
Benzinga· 19 hours agoA 5th Consecutive Year of Positive Free Cash Flow VANCOUVER, BC, May 7, 2024 /CNW/ - C21 Investments Inc. (CSE:CXXI) and (OTCQX:CXXIF) ("C21" or the "Company"), a vertically integrated cannabis company,
ANB Canada Announces Delay in Filing Annual Audited Financial Statements
Digital Journal· 6 days agoPlatform Brera Holdings Announces FENIX Trophy Final Four Matches set for May 10-12 Northern Graphite Provides Development...Regulation Crowdfunding Offering Obsidian Energy ...
Zacks Research Analysts Cut Earnings Estimates for Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)
ETF DAILY NEWS· 3 days agoDeciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Free Report) – Zacks Research decreased their Q1 2025 earnings per share estimates for Deciphera Pharmaceuticals in a report released on Wednesday ...
Marinus Verwijs Sells 1,981 Shares of Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Stock
ETF DAILY NEWS· 3 days agoAerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) insider Marinus Verwijs sold 1,981 shares of the firm’s stock in a transaction that occurred on Thursday, May 2nd. The stock was sold ...
Earnings call: Vir Biotechnology reports Q1 2024 financials, pipeline progress
Investing.com· 6 days agoVir Biotechnology reported a decrease in total revenues to $56.4 million in Q1 2024 from $63 million...